Hot Features
Premium
Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 10,562 |
|
|||||
| News | - | ||||||
| Day High | 4.66 | Low High |
|||||
| Day Low | 4.4001 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Moleculin Biotech Inc | MBRX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.1265 | 2.80% | 4.65 | 16:35:32 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 4.59 | 4.4001 | 4.66 | 4.65 | 4.5235 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 430 | 10,562 | US$ 4.49 | US$ 47,372 | - | 4.28 - 15.75 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:03 | 83 | US$ 4.65 | USD |
Moleculin Biotech Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 151.69M | 33.41M | - | 0 | -29.77M | -0.89 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Moleculin Biotech News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MBRX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.82 | 5.00 | 4.28 | 4.47 | 22,814 | -0.17 | -3.53% |
| 1 Month | 5.68 | 6.24 | 4.28 | 5.23 | 86,230 | -1.03 | -18.13% |
| 3 Months | 7.35 | 10.35 | 4.28 | 7.20 | 118,761 | -2.70 | -36.73% |
| 6 Months | 9.00 | 15.75 | 4.28 | 8.61 | 153,421 | -4.35 | -48.33% |
| 1 Year | 13.05 | 15.75 | 4.28 | 9.00 | 160,514 | -8.40 | -64.37% |
| 3 Years | 50.85 | 59.85 | 4.28 | 25.33 | 166,269 | -46.20 | -90.86% |
| 5 Years | 21.75 | 131.70 | 4.28 | 26.50 | 1,029,945 | -17.10 | -78.62% |
Moleculin Biotech Description
| Moleculin Biotech Inc is a clinical-stage pharmaceutical company with a focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next-generation anthracycline; Immune/Transcription Modulators, of which WP1066 is a member; and Metabolism/Glycosylation Inhibitors, of which WP1122 is a member. |
